Low level β-lactamase production in methicillin-resistant staphylococcus aureus strains with β-lactam antibiotics-induced vancomycin resistance

BMC Microbiology

Volumn 12, Issue , 2012, Pages

  Hirao, Yuriko ^a,b   Ikeda Dantsuji, Yurika ^a   Matsui, Hidehito ^a   Yoshida, Masaki ^c   Hori, Seiji ^c   Sunakawa, Keisuke ^a   Nakae, Taiji ^a   Hanaki, Hideaki ^a  

^a KITASATO UNIVERSITY   (Japan)

^b Japan   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

lactam; lactamase; Antibiotic resistance; MRSA; Staphylococcus aureus; Vancomycin

Indexed keywords

AMINO ACID; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; VANCOMYCIN; ANTIINFECTIVE AGENT; BACTERIAL DNA; BETA LACTAM;

AMINO ACID SUBSTITUTION; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BLAZ GENE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME SYNTHESIS; GENE AMPLIFICATION; GENE SEQUENCE; HUMAN; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; ANTIBIOTIC RESISTANCE; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SECRETION (PROCESS);

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; DNA, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; POLYMERASE CHAIN REACTION; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 84860649554     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-12-69     Document Type: Article

References (24)

1. A 25-year trace of methicillin-resistant Staphylococcus aureus dissemination in a geriatric hospital in Japan. Sakai F, Hanaki H, Barada K, Hirao Y, Inamatsu T, Nakae T, Sunakawa K, Internl J Gen Med 2010 3 399 405
2. Staphylococcus aureus nosocomial infections: the role of a rapid and low-cost characterization for the establishment of a surveillance system. Valaperta R, Tejada MR, Frigerio M, Moroni A, Ciulla E, Cioffi S, Capelli P, Costa E, New Microbiol 2010 33 223 232 20954440
3. Serious infection caused by methicillin-resistant Staphylococcus aureus. Boucher H, Miller LG, Razonable RR, Clin Infect Dis 2010 51 Suppl 2 183 S179 20731576
4. Specificity of combination between mucopeptide precursors and vancomycin or ristocetin. Perkins HR, Biochem J 1969 111 195 205 5763787
5. The chemical basis for the action of the vancomycin group of antibiotics. Perkins HR, Nieto M, Ann NY Acad Sci 1974 235 348 363 10.1111/j.1749-6632.1974. tb43276.x 4369274
6. Vancomycin revisisted: a reappraisal of clinical use. Cunha BA, Crit Care Clin 2008 24 393 420 10.1016/j.ccc.2007.12.012 18361953 (Pubitemid 351400623)
7. Combined effects of vancomycin and imipenem against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo. Totsuka K, Shiseki M, Kikuchi K, Matsui Y, J Antimicrob Chemother 1999 44 455 460 10.1093/jac/44.4.455 10588305 (Pubitemid 29490614)
8. Clinical studies on vancomycin in the treatment of MRSA infection (article in Japanese). Shimizu K, Orizu M, Kanno H, K S, Konishi T, Soma K, Nishitani H, Noguchi Y, Hasegawa S, Hasegawa H, et al. Jpn J Antibiot 1996 49 782 799 9053533 (Pubitemid 26301358)
9. Improved method of detection of -lactam antibiotic-induced VCM-resistant MRSA (BIVR). Hanaki H, Yamaguchi Y, Barata K, Sakai H, Sunakawa K, Intl J Antimicrob Agents 2004 23 311 313 (Pubitemid 38283604)
10. Investigation of -lactam antibiotic-induced vancomycin-resistant MRSA (BIVR). Hanaki H, Yamaguchi Y, Yanagisawa C, Uehara K, Matsui H, Yamaguchi Y, Hososaka YH, Barada K, Sakai F, Itabashi Y, et al. J Infect Chemother 2005 11 104 106 10.1007/s10156-004-0371-x 15856381 (Pubitemid 40645885)
11. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. Hanaki H, Kuwahara-Arai K, Boyle-Vavra S, Daum RS, Labischinski H, Hiramatsu K, J Antimicrob Chemother 1998 42 199 209 10.1093/jac/42.2.199 9738837 (Pubitemid 28393588)
12. Bacterial cell wall recycling provides cytosolic muropeptides as effectors for -lactamase induction. Jacobs C, Huang L, Bartowsky E, Normark S, Park JT, EMBO J 1994 13 4684 4694 7925310 (Pubitemid 24310220)
13. Rapid depletion of free vancomycin in medium in the presence of -lactam antibiotics and growth restoration in Staphylococcus aureus strain with -lactam-induced vancomycin resistance. Yanagisawa C, Hanaki H, Matsui H, Ikeda S, Nakae T, Sunakawa K, Antimicrob Agents Chemother 2009 53 63 68 10.1128/AAC.00762-08 18936187
14. Life in the Balance:Cell walls and antibiotic resistance. Jacobs C, Science 1997 278 1731 1732 9411793 (Pubitemid 27527629)
15. Antimicrobial resistance: the example of Staphylococcus aureus. Lowy FD, J Clinl Invest 2003 111 1265 1273 (Pubitemid 36554694)
16. Low-affinity penicillin-binding protein associated with, -lactam resistance in Staphylococcus aureus. Hartman BJ, Tomasz A, J Bacteriol 1984 158 513 516 6563036 (Pubitemid 14147618)
17. An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci. Pinho MG, de Lencastre H, Tomasz A, Proc Nat Acad Sci 2001 98 10886 10891 10.1073/pnas.191260798 11517340 (Pubitemid 32878714)
18. Role of an altered penicillin-binding protein in methicillin- and cephem-resistant Staphylococcus aureus. Utsui Y, Yokota T, Antimicrob Agents Chemother 1985 28 397 403 10.1128/AAC.28.3.397 3878127 (Pubitemid 15016630)
19. Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Martineau F, Picard FJ, Lansac N, Menard C, Roy PH, Ouellette M, Bergeron MG, Antimicrob Agents Chemother 2000 44 231 238 10.1128/AAC.44.2.231-238.2000 10639342 (Pubitemid 30060711)
20. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, Fukuchi Y, Kobayashi I, Lancet 1997 350 1670 1673 10.1016/S0140-6736(97)07324-8 9400512 (Pubitemid 28036828)
21. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Kuroda M, Ohota T, Uchiyama I, Baba T, Yuzawa H, Kobayasi I, Cui L, Oguchi A, Aoki K, Nagai Y, et al. Lancet 2001 357 1225 1240 10.1016/S0140-6736(00)04403-2 11418146 (Pubitemid 32539050)
22. Method of detecting -lactam antibiotic induced vancomycin resistant MRSA (BIVR). Hanaki H, Yamaguchi Y, Nomura S, Haraga I, Nagayama A, Sunakawa K, Intl J Antimicrob Agents 2004 23 1 5 (Pubitemid 38083303)
23. Novel method for detection do -lactamases by using a chromogenic chephalosporin substrate. OCallaghan CH, Morris A, Kirby SM, Shingler AH, Antimicrob Agents Chemother 1972 1 283 288 10.1128/AAC.1.4.283 4208895
24. Clinical and Laboratory Standards Institute, Performance standards for antimicrobial susceptibility testing; 15th informantional supplement. CLSI/NCCLS document M100-S15 Wayne, PA Clinical and Laboratory Standards Institute, Wayne PA, USA 2005 22723648